Cargando…

Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls

OBJECTIVES: For selection of high-risk systemic lupus erythematosus (SLE) patients it is necessary to obtain indicators of disease severity that predict disease damage. As in systemic sclerosis, nailfold capillary abnormalities could be such a biomarker in SLE. The primary objective of this cross-se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schonenberg-Meinema, Dieneke, Bergkamp, Sandy C, Nassar-Sheikh Rashid, Amara, van der Aa, Leontien B, de Bree, Godelieve J, ten Cate, Rebecca, Cutolo, Maurizio, Hak, A Elisabeth, Hissink Muller, Petra CE, van Onna, Marieke, Kuijpers, Taco W, Smith, Vanessa, van den Berg, J Merlijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Pediatric Lupus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020305/ https://www.ncbi.nlm.nih.gov/pubmed/33657918 http://dx.doi.org/10.1177/0961203321998750

Ejemplares similares

Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-up
por: Schonenberg-Meinema, Dieneke, et al.
Publicado: (2022)

Correlations between capillary density and degree of skin pigmentation in healthy children analysed by nailfold video capillaroscopy
por: Bergkamp, Sandy C., et al.
Publicado: (2023)

Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study
por: van Gulik, E. Charlotte, et al.
Publicado: (2020)

Exploring contrast-enhanced MRI findings of the clinically non-inflamed symptomatic pediatric wrist
por: Verkuil, Floris, et al.
Publicado: (2020)

Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis
por: Hemke, Robert, et al.
Publicado: (2015)

MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis
por: Barendregt, Anouk M, et al.
Publicado: (2020)

Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients
por: Nusman, Charlotte M., et al.
Publicado: (2015)

Contrast-enhanced MRI findings of the knee in healthy children; establishing normal values
por: Hemke, Robert, et al.
Publicado: (2017)

Double inversion recovery MRI versus contrast-enhanced MRI for evaluation of knee synovitis in juvenile idiopathic arthritis
por: Verkuil, Floris, et al.
Publicado: (2022)

Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents
por: Barendregt, Anouk M., et al.
Publicado: (2017)

Joint inflammation assessed by physical examination and MRI of the knee in juvenile idiopathic arthritis: low predictive value for synovitis
por: Nusman, Charlotte M, et al.
Publicado: (2014)

Dynamic contrast-enhanced magnetic resonance imaging of the wrist in children with juvenile idiopathic arthritis
por: Nusman, Charlotte M., et al.
Publicado: (2016)

Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee
por: van Gulik, E. Charlotte, et al.
Publicado: (2018)

Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study
por: Melsens, Karin, et al.
Publicado: (2022)

Systemic lupus erythematosus: state of the art on clinical practice guidelines
por: Tamirou, Farah, et al.
Publicado: (2019)

White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms
por: Monahan, Rory Caitlin, et al.
Publicado: (2021)

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
por: Monahan, Rory C, et al.
Publicado: (2022)

Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms
por: Gegenava, Maka, et al.
Publicado: (2019)

Rituximab in Idiopathic Pulmonary Hemosiderosis in Children: A Novel and Less Toxic Treatment Option
por: Terheggen-Lagro, Suzanne W. J., et al.
Publicado: (2022)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
por: Nassar-Sheikh Rashid, A., et al.
Publicado: (2021)

Comparison of contrast-enhanced MRI features of the (teno)synovium in the wrist of patients with juvenile idiopathic arthritis and pediatric controls
por: van der Krogt, Jeffrey M. A., et al.
Publicado: (2021)

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies
por: Holmqvist, Marie, et al.
Publicado: (2015)

Role of P-glycoprotein on CD69(+)CD4(+) cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy
por: Tsujimura, Shizuyo, et al.
Publicado: (2017)

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive women
por: Meisgen, Sabrina, et al.
Publicado: (2017)

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience
por: Tani, Chiara, et al.
Publicado: (2019)

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
por: Flint, Shaun M, et al.
Publicado: (2016)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
por: Kostopoulou, Myrto, et al.
Publicado: (2020)

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2019)

Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective
por: Pons-Estel, Guillermo J, et al.
Publicado: (2020)

The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial
por: Keramiotou, Kyriaki, et al.
Publicado: (2020)

Escaping the catch 22 of lupus anticoagulant testing
por: Vinholt, Pernille Just, et al.
Publicado: (2020)

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus
por: Elefante, Elena, et al.
Publicado: (2020)

Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
por: Yazdany, Jinoos, et al.
Publicado: (2020)

Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment
por: Davies, Jennifer C, et al.
Publicado: (2020)

Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus
por: Strasser, Daniel S, et al.
Publicado: (2020)

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy
por: Baker, Matthew, et al.
Publicado: (2020)

High p16(INK4a), a marker of cellular senescence, is associated with renal injury, impairment and outcome in lupus nephritis
por: Tilman, Gaëlle, et al.
Publicado: (2021)

Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series
por: Assawasaksakul, Theerada, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g88osh96v3pn4fi5fde0juj568